Pfizer Provides Topline Results From Phase 3 Study Of Torisel® As Second-Line Treatment In Advanced Renal Cell ...
Pfizer Inc announced today that the Phase 3 INTORSECT study, evaluating TORISEL® in patients with advanced renal cell carcinoma whose disease had progressed on or after SUTENT® therapy, did not meet the primary endpoint of prolonging progression free survival when compared to sorafenib.
Read more...
Press Release
Pfizer Inc announced today that the Phase 3 INTORSECT (B1771003) study, evaluating TORISEL® (temsirolimus) in patients with advanced renal cell carcinoma (RCC) whose disease had progressed on or after SUTENT® (sunitinib malate) therapy, did not meet the primary endpoint of prolonging progression free survival (PFS) when compared to sorafenib.
Read more...
Cardiff ponder kit change from blue to red
Cardiff are considering a proposal to change the colour of their kit to red. Sportsmail understands it is one of a number of options being considered by the club's board.
Read more...
Cardiff ponder kit change from blue to red as Asian owners consider shake-up
Cardiff are considering a proposal to change the colour of their kit to red. Sportsmail understands it is one of a number of options being considered by the club's board as part of a rebranding exercise to boost their chances of attracting greater revenues.
Read more...
Bluebirds heading into the red?
Cardiff are considering a proposal to change the colour of their kit to red.
Read more...
|
